European Health and Social Equity Federation (EHSEF)
People's health at the centre of every policy
Medical research, treatments and the parliamentary decisions affecting your health.
Initial edition: 2 November 2026 · 15 news briefs
Showing 15 news briefs. Publication dates and official sources are stated below.
23 October 2026 · NIH
NIH reports research linking an additional year of secondary education with fewer dementia diagnoses later in life. This is a population finding, not an individual prevention guarantee.
Read the official source →23 October 2026 · NIH
A clinical trial reports activity from an experimental approach targeting tumour-fighting T cells. Further evidence is needed before conclusions about routine care.
Read the official source →14 October 2026 · NIH
A retrospective study explores a possible link between a blood-pressure drug and brown fat activity. It does not establish a new prescribing indication.
Read the official source →13 October 2026 · NIH
An NIH-funded clinical study explores real-time communication with an epilepsy monitoring system to support seizure detection.
Read the official source →7 October 2026 · NIH
Laboratory lung models with immune-system components reproduced adaptive responses to viral infection, offering a research tool rather than a treatment.
Read the official source →12–15 October 2026 meeting · EMA / CHMP
EMA’s committee issued a positive opinion for daraxonrasib in adults with previously treated metastatic pancreatic adenocarcinoma. A committee recommendation is distinct from final authorisation.
Read the official source →12–15 October 2026 meeting · EMA / CHMP
The committee recommended Foundayo, containing orforglipron, for adult weight management and type 2 diabetes. Consult the regulatory source for the precise scope.
Read the official source →12–15 October 2026 meeting · EMA / CHMP
CHMP recommended marketing authorisation for Yuviwel, containing navepegritide, for children with achondroplasia.
Read the official source →12–15 October 2026 meeting · EMA / CHMP
Fovlussea received a favourable committee opinion for specified retinal disorders, including wet age-related macular degeneration.
Read the official source →12–15 October 2026 meeting · EMA / CHMP
CHMP issued a positive opinion for Neuzafy for neutropenia in adults and children.
Read the official source →12–15 October 2026 meeting · EMA / CHMP
Kizfizo received a positive opinion for adult glioblastoma and childhood malignant glioma. This is a regulatory development, not a newly discovered cure.
Read the official source →28 September 2026 · Council of the European Union
The Council announced adoption of the pharma package on access, innovation and supply security. Its release identified European Parliament adoption as a further step. Consult the legislative record for subsequent developments.
Read the official source →29 October 2026 · UK Parliament
The parliamentary update announced further committee-stage examination on 3 November. Committee scrutiny does not mean a bill is already law.
Read the official source →2026 parliamentary dossier · Deutscher Bundestag
The parliamentary dossier tracks plans to improve coordination between out-of-hours services, emergency departments and rescue services. See the original record for the latest legislative stage.
Read the official source →October 2026 dossier · French Senate
The legislative dossier records the financing bill and committee reports, and an Assembly rejection on 23 October. Follow the dossier for the subsequent parliamentary process.
Read the official source →